Physician profile
Jerri Johnson
NPI 1588648265
$1,855.20
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $525 · 2020: $341 · 2021: $483 · 2022: $506.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $308.43 | 2019-2022 | |
| Ucb, INC. | $232.69 | 2019-2022 | |
| Pfizer INC. | $168.02 | 2019-2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $165.41 | 2019-2021 | |
| Genentech USA, INC. | $136.70 | 2019-2021 | |
| Mayne Pharma Commercial LLC | $102.01 | 2019-2022 | |
| Almirall LLC | $96.28 | 2021-2022 | |
| Amgen INC. | $92.32 | 2020-2021 | |
| Sun Pharmaceutical Industries INC. | $74.12 | 2019-2022 | |
| Genzyme Corporation | $72.40 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $72.00 | 2021 | |
| Leo Pharma INC. | $60.01 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $45.74 | 2019 | |
| Celgene Corporation | $44.37 | 2019 | |
| Lilly USA, LLC | $39.07 | 2019-2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $28.48 | 2020-2022 | |
| Dermavant Sciences, INC. | $26.03 | 2022 | |
| Janssen Biotech, INC. | $25.35 | 2019 | |
| Dermira, INC. | $19.76 | 2019 | |
| Incyte Corporation | $16.96 | 2022 | |
| Nabriva Therapeutics, Plc | $16.49 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $12.56 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jerri Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.